Cleveland HeartLab is a leading brand offering innovative and scientifically proven biomarkers that are instrumental in predicting cardiovascular risk. Their comprehensive range of inflammatory and advanced biomarker tests are utilized by healthcare practitioners worldwide for the prevention and management of heart disease. These cutting-edge biomarker technologies are available through their highly accredited clinical reference laboratory that adheres to strict quality standards.

Additionally, Cleveland HeartLab maintains a dedicated research and development lab where they continue to develop next-generation cardiovascular disease biomarkers for use in their clinical laboratory. With a focus on evidence-based science and clinical testing, Cleveland HeartLab's mission is to assist clinicians in identifying risks and reducing cardiovascular events. They strive to be the premier cardiovascular testing provider by offering superior quality solutions and maintaining a solutions-oriented attitude.

The brand's areas of expertise include innovation, inflammation, and education. Their ongoing research collaborations with leading academic and medical institutions allow them to introduce unique biomarker technologies to the market. Cleveland HeartLab is widely recognized for their expertise in inflammation testing and offers a multi-marker approach that provides additional insights into individual cardiovascular risk, leading to more effective treatment.

They are committed to educating healthcare providers and patients through CME-accredited events, medical forums, and online resources. Cleveland HeartLab stands at the forefront of cardiovascular testing, dedicated to improving patient outcomes and reducing the burden of cardiovascular disease